The Enzyme-linked Immunosorbent Assay: Accurate Detection of Red Blood Cell Antibodies in Autoimmune Hemolytic Anemia
DAVID C. BODENSTEINER, Peggy J. Brown, Barry Skikne, Fred V. Plapp
Abstract
DAVID C. BODENSTEINER, Peggy J. Brown, Barry Skikne, Fred V. Plapp
Abstract
The enzyme-linked immunosorbent assay (ELISA) was employed in the study of red blood cells from patients with autoimmune hemolytic anemia. The ELISA was more sensitive and correlated with severity of hemolysis better than the direct antiglobulin test (DAT). It was helpful in diagnosing and following the clinical course in these patients. This was particularly true in the DAT-negative group, since the ELISA can detect smaller increases in red blood cell IgG than are required for a positive DAT.
OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The enzyme-linked immunosorbent assay (ELISA) was employed in the study of red blood cells from patients with autoimmune hemolytic anemia. The ELISA was more sensitive and correlated with severity of hemolysis better than the direct antiglobulin test (DAT). It was helpful in diagnosing and following the clinical course in these patients. This was particularly true in the DAT-negative group, since the ELISA can detect smaller increases in red blood cell IgG than are required for a positive DAT.
Key concepts: Hemolysis, Autoimmune hemolytic anemia, Antibody, Immunology, Hemolytic anemia, Red blood cell, Coombs test, Medicine